Real-time MRI for precise and predictable intra-arterial stem cell delivery to the central nervous system

Journal of Cerebral Blood Flow and Metabolism

Volumn 37, Issue 7, 2017, Pages 2346-2358

  Walczak, Piotr ^a,b   Wojtkiewicz, Joanna ^b   Nowakowski, Adam ^c   Habich, Aleksandra ^b   Holak, Piotr ^b   Xu, Jiadi ^d   Adamiak, Zbigniew ^b   Chehade, Moussa ^a   Pearl, Monica S ^a   Gailloud, Philippe ^a   Lukomska, Barbara ^c   Maksymowicz, Wojciech ^b   Bulte, Jeff WM ^a   Janowski, Miroslaw ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^d KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Intra arterial; iron oxide; MRI; real time; stroke

Indexed keywords

ANTIINFECTIVE AGENT; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETERIZATION; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BRAIN TISSUE; CELL LABELING; CENTRAL NERVOUS SYSTEM; CENTRAL VENOUS CATHETERIZATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DOG; FLUOROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMAGE PROCESSING; INTERNAL CAROTID ARTERY; LACUNAR STROKE; MALE; MESENCHYMAL STEM CELL; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PIG; PRIORITY JOURNAL; RAT; REAL TIME TRACKING SYSTEM; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; ANIMAL; BRAIN ARTERY; CAROTID ARTERY; CELL TRACKING; CYTOLOGY; DIAGNOSTIC IMAGING; DISEASE MODEL; INTRAARTERIAL DRUG ADMINISTRATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PROCEDURES; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT; STROKE; WISTAR RAT;

ANIMALS; CAROTID ARTERIES; CELL TRACKING; CEREBRAL ARTERIES; DISEASE MODELS, ANIMAL; DOGS; INFUSIONS, INTRA-ARTERIAL; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SPECIES SPECIFICITY; STROKE; SWINE;

EID: 85021082948     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16665853     Document Type: Article

References (33)

1. Takahashi K, Tanabe K, Ohnuki M. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861–872.
2. Janowski M, Wagner DC, Boltze J. Stem cell-based tissue replacement after stroke: factual necessity or notorious fiction? Stroke 2015; 46: 2354–2363.
3. Janowski M, Engels C, Gorelik M. Survival of neural progenitors allografted into the CNS of immunocompetent recipients is highly dependent on transplantation site. Cell Transplant 2014; 23: 253–262.
4. Cougo-Pinto PT, Chandra RV, Simonsen CZ. Intra-arterial therapy for acute ischemic stroke: a golden age. Curr Treat Opt Neurol 2015; 17: 360.
5. Gorelik M, Orukari I, Wang J. Use of MR cell tracking to evaluate targeting of glial precursor cells to inflammatory tissue by exploiting the very late antigen-4 docking receptor. Radiology 2012; 265: 175–185.
6. Guzman R, De Los Angeles A, Cheshier S. Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke 2008; 39: 1300–1306.
7. Janowski M, Lyczek A, Engels C. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab 2013; 33: 921–927.
8. Cui LL, Kerkela E, Bakreen A. The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res Ther 2015; 6: 11.
9. Walczak P, Kedziorek DA, Gilad AA. Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn Reson Me 2007; 58: 261–269.
10. Puppi J, Mitry RR, Modo M. Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes. Cell Transplant 2011; 20: 963–975.
11. Puppi J, Modo M, Dhawan A. Ex vivo magnetic resonance imaging of transplanted hepatocytes in a rat model of acute liver failure. Cell Transplant 2013; 23: 329–343.
12. Song M, Kim Y, Kim Y. MRI tracking of intravenously transplanted human neural stem cells in rat focal ischemia model. Neurosci Res 2009; 64: 235–239.
13. Bulte JW. In vivo MRI cell tracking: clinical studies. AJR Am JRoentgenol 2009; 193: 314–325.
14. Sheu AY, Zhang Z, Omary RA. MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model. Invest Radiol 2013; 48: 492–499.
15. Walczak P, Zhang J, Gilad AA. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008; 39: 1569–1574.
16. Janowski M, Walczak P, Pearl MS. Predicting and optimizing the territory of blood-brain barrier opening by superselective intra-arterial cerebral infusion under dynamic susceptibility contrast MRI guidance. J Cereb Blood Flow Metab 2016; 36: 569–575.
17. Song X, Walczak P, He X, et al. Salicylic acid analogues as chemical exchange saturation transfer mri contrast agents for the assessment of brain perfusion territory and blood-brain barrier opening after intra-arterial infusion. J Cereb Blood Flow Metab 2016; 36: 1186–1194
18. Phillips AW, Falahati S, DeSilva R. Derivation of glial restricted precursors from E13 mice. J Vis Exp 2012; 64: pii 3462.
19. Muhammad G, Jablonska A, Rose L. Effect of MRI tags: SPIO nanoparticles and 19F nanoemulsion on various populations of mouse mesenchymal stem cells. Acta Neurobiol Exp (Wars) 2015; 75: 144–159.
20. Kedziorek DA, Muja N, Walczak P. Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn Reson Med 2010; 63: 1031–1043.
21. Janowski M, Gornicka-Pawlak E, Kozlowska H. Structural and functional characteristic of a model for deep-seated lacunar infarct in rats. J Neurol Sci 2008; 273: 40–48.
22. Janowski M, Lyczek A, Engels C. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab 2013; 33: 921–927.
23. Gorelik M, Janowski M, Galpoththawela C. Noninvasive monitoring of immunosuppressive drug efficacy to prevent rejection of intracerebral glial precursor allografts. Cell Transplant 2012; 21: 2149–2157.
24. Thornhill RE, Chen S, Rammo W. Contrast-enhanced MR imaging in acute ischemic stroke: T2* measures of blood-brain barrier permeability and their relationship to T1 estimates and hemorrhagic transformation. AJNR Am J Neuroradiol 2010; 31: 1015–1022.
25. Yavagal DR, Lin B, Raval AP. Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. PloS One 2014; 9: e93735.
26. Toyoshima A, Yasuhara T, Kameda M. Intra-arterial transplantation of allogeneic mesenchymal stem cells mounts neuroprotective effects in a transient ischemic stroke model in rats: analyses of therapeutic time window and its mechanisms. PloS One 2015; 10: e0127302.
27. Du S, Guan J, Mao G. Intra-arterial delivery of human bone marrow mesenchymal stem cells is a safe and effective way to treat cerebral ischemia in rats. Cell Transplant 2014; (23 Suppl 1): S73–S82.
28. Zeira O, Asiag N, Aralla M. Adult autologous mesenchymal stem cells for the treatment of suspected non-infectious inflammatory diseases of the canine central nervous system: safety, feasibility and preliminary clinical findings. J Neuroinflammation 2015; 12: 181.
29. Silachev DN, Plotnikov EY, Babenko VA. Intra-arterial administration of multipotent mesenchymal stromal cells promotes functional recovery of the brain after traumatic brain injury. Bull Exp Biol Med 2015; 159: 528–533.
30. Oh SH, Choi C, Chang DJ. Early neuroprotective effect with lack of long-term cell replacement effect on experimental stroke after intra-arterial transplantation of adipose-derived mesenchymal stromal cells. Cytotherapy 2015; 17: 1090–1103.
31. Yang B, Migliati E, Parsha K. Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke 2013; 44: 3463–3472.
32. Brenneman M, Sharma S, Harting M. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab 2010; 30: 140–149.
33. Erturk MA, El-Sharkawy AM, Bottomley PA. Interventional loopless antenna at 7 T. Magn Reson Med 2012; 68: 980–988.